top of page

Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

About the study

NCT Trial Number

NCT03065335

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC)

noun_date_3237048.png

Trial Start Date

May-17

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

Yes

This study explores effects of ketamine in treating depression and how ketamine effects the brain.

Eyes Graffiti

Locations

United States, Maryland
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892

Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
800-411-1222 ext TTY8664111010
prpl@cc.nih.gov

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page